• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

byTeddy Guo
April 28, 2023
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

 

Click to read this study in The Lancet Oncology. 

RELATED REPORTS

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

Tags: advanced melanomaAtezolizumabBRAF-mutated melanomacobimetinibcutaneous melanomafulminant hepatitishepatic failureliver failuremelanomaskin cancerVemurafenib
Previous Post

Neuropsychological and biomechanical measures dominate assessment of limb pain in athletes

Next Post

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

RelatedReports

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment
StudyGraphics

#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment

November 10, 2023
Stereotactic radiosurgery promising for patients with multiple brain metastases
Oncology

Atezolizumab, Vemurafenib, and Cobimetinib in Melanoma With CNS Metastases

October 9, 2023
Key predictors of recurrence and survival for Merkel Cell Carcinoma elucidated
Chronic Disease

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

September 21, 2023
Increased frailty associated with childhood cancer survivorship
Oncology

Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma

September 18, 2023
Next Post
#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Specific viruses may be associated with increased risk and worse outcomes of ovarian cancer
  • Low-dose amitriptyline effective and well-tolerated for management of irritable bowel syndrome
  • Patisiran prevents functional decline in patients with cardiac amyloidosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options